Pharmacologic Characteristics of Indinavir, Didanosine, and Stavudine in Human Immunodeficiency Virus-Infected Children Receiving Combination Therapy

Lignende værker

• Pharmacological Basis for Concentration-Controlled Therapy with Zidovudine, Lamivudine, and Indinavir
  af: Kakuda, Thomas N., et al.
  Udgivet: (2001)
• Pharmacokinetics of Stavudine and Didanosine Coadministered with Nelfinavir in Human Immunodeficiency Virus-Exposed Neonates
  af: Rongkavilit, Chokechai, et al.
  Udgivet: (2001)
• If Taken 1 Hour before Indinavir (IDV), Didanosine Does Not Affect IDV Exposure, despite Persistent Buffering Effects
  af: Shelton, Mark J., et al.
  Udgivet: (2001)
• Population Pharmacokinetics of Indinavir in Patients Infected with Human Immunodeficiency Virus
  af: Csajka, Chantal, et al.
  Udgivet: (2004)
• Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patients.
  af: Seifert, R D, et al.
  Udgivet: (1994)